ArticleNature communications2026
Divergent C2 functionalization of N-Heteroarenes via nonclassical rearomatization.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Site-selective functionalization of N-heteroarenes remains a persistent challenge due to their intrinsic aromatic stabilization and multiple reactive sites. We present a unified strategy that redirects the reactivity of N-alkenyloxy-heteroarenium salts to access two distinct product classes. Under Grignard-reagent conditions, pyridinium substrates undergo ultrafast C2-functionalization via a concerted, six-electron retro-hetero-ene rearrangement-a transformation not previously described-delivering ortho-substituted pyridines (alkyl, aryl, heteroaryl, alkynyl) in up to 93% yield. In contrast, quinolinium salts engage in a cascade involving C2‑addition, a 3,3‑sigmatropic rearrangement, cycloaddition and dehydration to furnish N‑bridged polycyclic frameworks efficiently. Notably, the reaction pathway is governed by substrate sterics; C8 substitution on quinoline switches the mechanism to the retro-hetero-ene route. The method is scalable, enables late-stage diversification of complexed scaffolds and site-selective deuterium labeling. Here we show that this strategy, supported by mechanistic and computational studies, establishes a versatile platform for heteroarene editing via nonclassical rearomatization.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.